Infectious disease assessment in solid organ transplant candidates;Evaluación de las enfermedades infecciosas en el candidato a un trasplante de órgano sólido

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 20, Issue 9, 2002, Pages 448-461

  Ayats Ardite, Josefina ^b   Cisneros Herreros, José Miguel ^b   Pérez Sáenz, José Luis ^a   De la Torre Cisneros, Julián ^b  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b NONE

Author keywords

Guidelines; Infections; Pretransplant valuation

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL VACCINE; BCG VACCINE; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGITIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; VIRUS VACCINE;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BCG VACCINATION; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; ORGAN TRANSPLANTATION; PRACTICE GUIDELINE; REVIEW; TUBERCULIN TEST; TUBERCULOSIS; VACCINATION; VIRUS DETECTION; VIRUS HEPATITIS; VIRUS INFECTION;

EID: 0036857809     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0213-005x(02)72841-3     Document Type: Review

References (11)

1. Blanes Juliá M, López Aldeguer J. Evaluación de la infección en el donante y en el receptor. En: Aguado JM, editor. Infecciones en Pacientes Trasplantados. Madrid: Harcourt, 2000;p. 23-40.
2. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.
3. Burroughs M, Moscona A. Immunization of pediatric solid organ transplant candidates and recipients. Clin Infect Dis 2000;30:857-69.
4. Carithers RL, Marquardt A, Gretch DR. Diagnostic testing for hepatitis C. Seminars Liver Dis 2000;20:159-71.
5. Larocco MT, Burgert SJ. Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation. Clin Microbiol Rev 1997;10:277-97.
6. Martinez-Marcos FJ, Lopez-Cortes LF, Pachon J, Alarcon A, Cordero E, Viciana P. Comparison of two methods for the assessment of delayed-type hypersensitivity skin in patients with human immunodeficiency virus infection. Clin Infect Dis 1998;26:1330-4.
7. Muñoz P, Bellido A, Bouza E. Aspectos generales de la prevención de la infección en el trasplante. En: Aguado JM, editor. Infecciones en Pacientes Trasplantados. Madrid: Harcourt, 2000;p. 97-132.
8. Murray BE. Drug therapy: Vancomycin-resistant enterococcal infections, N Engl J Med 2000;342:710-21.
9. Patel R, Paya CV. Infections in solid organ transplant recipients. Clin Microbiol Rev 1997;10:86-124.
10. Pérez JL, Ayats J. El laboratorio de microbiología en el trasplante. En: Aguado JM, editor. Infecciones en Pacientes Trasplantados. Madrid: Harcourt, 2000; p. 97-132.
11. Torre Cisneros J, De la Mata M, Rufian S, Villanueva Marcos JL, Gutierrez-Aroca J, Casal M, et al Importance of surveillance mycobacterial cultures after liver transplantation. Transplantation 1995;60:1054-5.